Glatiramer

CHEBI:CHEBI_750943

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

generic_name
GLATIRAMER ACETATE
rxcui
1487361
product_type
BULK INGREDIENT
listing_expiration_date
20241231
marketing_category
BULK INGREDIENT
dosage_form
INJECTION, SOLUTION
route
SUBCUTANEOUS
active_ingredient_strength
25 kg/25kg
marketing_start_date
20120906
labeler_name
Ambiopharm, Inc.
package_marketing_start_date
09-OCT-12
brand_name
Glatiramer Acetate
brand_name_base
Glatiramer Acetate
active_ingredient_name
GLATIRAMER
unii
5M691HL4BO
manufacturer_name
Mylan Pharmaceuticals Inc.
product_ndc
41524-0004
application_number
ANDA206936
spl_id
a7d297de-acc0-9808-e053-2995a90ad078
package_ndc
41524-0004-1
package_description
1 g in 1 BOTTLE (41524-0004-1)
spl_set_id
456a34c7-8511-4000-99a7-ad8f8de6d35e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class